Literature DB >> 10192465

Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation.

P Bavaro, G Di Girolamo, P Olioso, G Papalinetti, A Iacone, P Accorsi, P Di Bartolomeo.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10192465     DOI： 10.1046/j.1365-2141.1999.1331d.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

Review 1.  Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.

Authors:  Javier Marco-Ayala; Inés Gómez-Seguí; Guillermo Sanz; Pilar Solves
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

2.  Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Authors:  Georg Stussi; Jörg Halter; Eveline Bucheli; Piero V Valli; Lutz Seebach; Jürg Gmür; Alois Gratwohl; Urs Schanz; Jakob R Passweg; Jörg D Seebach
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

3.  The effect of donor leukocyte infusion on refractory pure red blood cell aplasia after allogeneic stem cell transplantation in a patient with myelodysplastic syndrome developing from Kostmann syndrome.

Authors:  Yasuhiro Ebihara; Atsushi Manabe; Toshihisa Tsuruta; Kumiko Ishikawa; Daisuke Hasegawa; Yoshitoshi Ohtsuka; Hirohide Kawasaki; Kazuo Ogami; Yuka Wada; Tadayasu Kanda; Kohichiro Tsuji
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

4.  Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sung-Hoon Jung; Jae-Sook Ahn; Deok-Hwan Yang; Hyung Chul Park; Soo-Young Bae; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-02-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.